Neonatal hyperoxia leads to white adipose tissue remodeling and susceptibility to hypercaloric diet

Alyson Deprez1,2, Marie-Amélie Lukaszewski1, Coraline De Sousa Do Outeiro1

  • 1Sainte Justine University Hospital (CHU Sainte-Justine) and Research Centre, Department of Pediatrics, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Physiological Reports
|July 11, 2023
PubMed

Insights

Preterm birth conditions alter white adipose tissue, increasing adult metabolic disease risk. Neonatal hyperoxia causes lasting tissue changes, making it more vulnerable to high-fat diets.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Metabolic Physiology

Background:

  • Preterm birth increases adult cardiovascular and metabolic disease risk.
  • White adipose tissue (WAT) is crucial for metabolic homeostasis.
  • The impact of preterm birth on WAT is not well understood.

Purpose of the Study:

  • To investigate the long-term effects of preterm birth conditions on white adipose tissue (WAT).
  • To assess the combined impact of neonatal hyperoxia and a hypercaloric diet on metabolic health.

Main Methods:

  • A rodent model simulating preterm birth conditions (neonatal hyperoxia).
  • Evaluation of adult perirenal WAT and liver after a high-fat, high-fructose diet (HFFD).
  • Analysis of WAT fibrosis, macrophage infiltration, adipocyte size, liver lipids, and triglycerides.

Main Results:

  • Neonatal hyperoxia induced WAT fibrosis and macrophage infiltration.
  • HFFD exacerbated metabolic dysfunction in hyperoxia-exposed rats, causing adipocyte hypertrophy, liver lipid accumulation, and increased triglycerides.
  • Preterm birth conditions led to lasting WAT changes and increased susceptibility to diet-induced metabolic harm.

Conclusions:

  • Preterm birth-related conditions have persistent, detrimental effects on WAT.
  • These changes suggest a developmental programming of WAT that contributes to long-term metabolic risk in adults born preterm.
  • WAT programming may underlie the increased metabolic disease risk observed in preterm-born individuals.